Search

Washington, D.C., November 24, 2021 – Saul Ewing LLP served as counsel to Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) in the successful completion today of its previously announced $450 million acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS). The acquisition strengthens Supernus'...

Saul Ewing, a full-service law firm with more than 400 attorneys in 16 offices, announced that it has been selected as Delaware counsel to the official committee of unsecured creditors in the bankruptcy proceedings of Forever 21, Inc. et al. ("Forever 21"), pending in the United States Bankruptcy...